MacroGenics, Inc. (MGNX) financial statements (2021 and earlier)

Company profile

Business Address 9704 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments181 220305277196
Cash and cash equivalents181 22021284196
Short-term investments   93193 
Receivables23 301431
Prepaid expense17 6332
Other undisclosed current assets91 1301143
Total current assets:313 269322284342
Noncurrent Assets
Property, plant and equipment42 57501815
Long-term investments and receivables    8 
Long-term investments    8 
Other noncurrent assets24 6212
Total noncurrent assets:66 63522717
TOTAL ASSETS:379 332374311359
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities42 37412015
Accounts payable8 4243
Accrued liabilities34 33391612
Deferred revenue4 
Deferred rent credit  1
Restructuring reserve   022
Deferred revenue and credits866
Other liabilities  00 1
Other undisclosed current liabilities4 22   
Total current liabilities:51 60502723
Noncurrent Liabilities
Long-term debt and lease obligation25     
Operating lease, liability25 
Liabilities, other than long-term debt7 10251523
Deferred revenue and credits251520
Deferred revenue7 
Deferred rent credit  10
Restructuring reserve    03
Other undisclosed noncurrent liabilities  19   
Total noncurrent liabilities:32 29251523
Total liabilities:83 89754346
Stockholders' equity
Stockholders' equity attributable to parent296 243299269313
Common stock1 0000
Additional paid in capital1,067 733611561547
Accumulated other comprehensive loss(0) (0)(0)(0)(0)
Accumulated deficit(772) (490)(312)(293)(234)
Total stockholders' equity:296 243299269313
TOTAL LIABILITIES AND EQUITY:379 332374311359

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenue, net15892101
Gross profit:105 6015892101
Operating expenses(236) (231)(180)(152)(121)
Operating loss:(131) (171)(22)(60)(20)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
1 (0)320
Net loss available to common stockholders, diluted:(130) (171)(20)(59)(20)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(130) (171)(20)(59)(20)
Comprehensive loss:(130) (171)(20)(59)(20)
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)     
Comprehensive loss, net of tax, attributable to parent:(130) (171)(20)(59)(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: